Tonia Silva CPC, CPMA, CPPM

Tonia Silva CPC, CPMA, CPPM Consultant in Podiatry & wound care coding & documentation compliance & NextGen Office start up assistance

Helpful resource.
03/01/2026

Helpful resource.

: HHS-OIG develops health care compliance resources to help health care providers, such as hospitals and physicians, understand and follow federal laws and regulations. To stay up to date, visit the OIG compliance portal: oig.hhs.gov/compliance/.

What to do about the expired ABN??CMS states directly on its Beneficiary Notices webpage:  “These notices may expire pri...
02/16/2026

What to do about the expired ABN??

CMS states directly on its Beneficiary Notices webpage:

“These notices may expire prior to the Office of Management and Budget (OMB) approval … providers and plans may continue using the current version of the notice after the expiration date … Providers and plans will have 60 calendar days from the date of the CMS notification to begin using the updated notice.”

Some MACs have already issued notices confirming this approach and instructing providers to continue using the existing form until further notice (CGS, Noridian).

📣📣This just in!! CMS and the DME MACs have confirmed that co-signed notes are not required when specific documentation s...
02/16/2026

📣📣This just in!! CMS and the DME MACs have confirmed that co-signed notes are not required when specific documentation standards are met. As per the APMA:
For Medicare coverage of therapeutic shoes for persons with diabetes, there is no need for the certifying physician to initial and date any of the podiatrist’s documentation if the certifying physician:

*Had an in-person visit with the beneficiary during which diabetes management was addressed within six months prior to delivery of the shoes

*Personally documents in the medical record of an in-person visit that the patient has diabetes and has one of the six conditions required for coverage of therapeutic shoes (and this occurs within six months prior to delivery of the shoes/inserts and prior to or on the same day as signing the certification statement)

*Documents that they are treating the beneficiary under a comprehensive plan of care for diabetes

*Documents that the patient needs diabetic shoes

*Signs the certification statement on or after the date of the in-person visit and within three months prior to delivery of the shoes/inserts

As confirmed in the DME MAC Policy article “Therapeutic Shoes for Persons with Diabetes” (A52501), if each of the five steps listed above are performed, there is no need for the certifying physician to initial and date any of the podiatrist’s documentation.

---With that said...having the MD sign off in agreement to the DPM note that states all of the above, may STILL be the easiest way to get these requirements into the MD chart.---

Use this page to view details for the Local Coverage Article for Therapeutic Shoes for Persons with Diabetes - Policy Article.

Guidance on new billing rules for skin subs.  Waste is no longer billable, so be sure to use a size appropriate for the ...
02/01/2026

Guidance on new billing rules for skin subs. Waste is no longer billable, so be sure to use a size appropriate for the wound. There are NO exceptions.

This webpage is used to structure an article produced by CMS or Noridian.

01/06/2026

As of January 6, 2026, the Physician Fee Schedule is still not available on cms.gov. Whatever that means, I dont know...but for now, when it comes to the vast majority of skin substitutes, those are priced at $127.14 per square cm.
The question has been asked "what do we do with the waste if a product only comes in one size?" Well...you better find a product that has more sizes available! Here is what Medicare is saying:

Q9. Should the JW and JZ modifiers be used when billing for separately payable incident-to supplies?
A9. The JW and JZ modifiers are only used when billing for drugs and biologicals separately payable under Medicare Part B as described in FAQ 8.
The JW and JZ modifiers are not appropriate for billing for incident-to supplies, even if such incident-to supplies are separately payable.

In addition, discarded amounts of incident-to supplies are not payable by Medicare.
..non-BLA skin substitutes are no longer payable under Medicare Part B as a drug or biological as of January 1, 2026, and only the administered portion is payable.

For dates of service starting January 1, 2026:
• If a provider or supplier administers an entire non-BLA skin substitute from the package or container (and no units are discarded), the JZ modifier is not appropriate when billing Medicare.
• If a provider or supplier administers a portion of a non-BLA skin substitute from the package or container and a portion is discarded, the provider or supplier may only bill for the units that are administered. It is not appropriate to bill Medicare for such discarded units under any circumstance (that is, such units may not be billed with the JW modifier and such units may not be included when billing for the administered amount).

Send a message to learn more

Well, they withdrew the LCD on skin subs...is the fee schedule next?
12/24/2025

Well, they withdrew the LCD on skin subs...is the fee schedule next?

Final Local Coverage Determinations (LCDs) for Certain Skin Substitutes Withdrawn Effective immediately, CMS’ A/B Medicare Administrative Contractors (MACs) are withdrawing the Local Coverage Determinations (LCDs) for Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of D...

This is why advise to be very careful with EHRs that code for you.   It's imperative that each provider review what is c...
12/24/2025

This is why advise to be very careful with EHRs that code for you. It's imperative that each provider review what is coded.

A North Carolina software company agreed to pay $529,069 to resolve allegations it violated the False Claims Act by causing providers to bill and MassHealth for medically unnecessary breast cancer screenings. Read more: https://direc.to/fS1e

THIS is why we are in the situation we are in currently in this industry...disgusting...
12/19/2025

THIS is why we are in the situation we are in currently in this industry...disgusting...

In the first prosecution of its kind, the owners of several Arizona wound graft companies were sentenced to significant terms of incarceration for causing over $1.2 billion of false and fraudulent claims to be submitted to Medicare and other health insurance programs for medically unnecessary wound....

CMS adds product coverage categories expanding the number of available CTPs for 2026.
12/16/2025

CMS adds product coverage categories expanding the number of available CTPs for 2026.

Upcoming Update to the Final Local Coverage Determinations (LCDs) for Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers All seven of CMS’ A/B Medicare Administrative Contractors (MACs) will issue updated Final Local Coverage D...

These changes are HUGE and have the potential to greatly affect patient care!
12/06/2025

These changes are HUGE and have the potential to greatly affect patient care!

Beginning January 1, 2026, Medicare Part B will introduce three major policy changes that directly affect how podiatrists provide and bill for skin substitute applications.

To support members through these updates, APMA has developed a concise 20-minute explainer video outlining what’s changing and what practices should prepare for now.

APMA members: Stay informed, stay compliant, and get ahead of the transition.

➡️ Watch the full breakdown here: https://us02web.zoom.us/rec/component-page?eagerLoadZvaPages=&accessLevel=meeting&hasValidToken=false&clusterId=us02&action=play&filePlayId=&componentName=recording-register&meetingId=-mBEOHZ5uIzueFF5S8hJkFK-LKchjfvIIDyw66vb7Ju7JU0PncyYlGBEYrBs7-Sk.tyy24ni_SB3sMMlQ&originRequestUrl=https%3A%2F%2Fus02web.zoom.us%2Frec%2Fshare%2Fd0nKr_LPXVyYQVSH4hKTGvdBq1lMIoDm5te2NKv_VngZKxZW6p9Ef57Y8nJtuAwb.BOFiVQ3KyPk8uttm%3FstartTime%3D1763581440000

Please take the survey.  I have been facilitating the proper documentation for DM shoes for  many years, even won an app...
12/06/2025

Please take the survey. I have been facilitating the proper documentation for DM shoes for many years, even won an appeal at the judicial level!! I can sincerely say that the requirements are burdensome and this directly affects patient care!
https://www.facebook.com/100064730044224/posts/1289559203211736/?mibextid=CDWPTG

APMA is gathering critical information on the documentation challenges podiatrists face when prescribing therapeutic footwear for patients with diabetes under Medicare, and we need your input.

Your input is essential to APMA's advocacy efforts as we work to reduce unnecessary administrative burdens and improve patient access.

Please take a couple of minutes to complete this four-question survey and help strengthen our data on documentation challenges:
https://www.surveymonkey.com/r/XS6GGLB

Address

Lakeport, CA
95453

Alerts

Be the first to know and let us send you an email when Tonia Silva CPC, CPMA, CPPM posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Tonia Silva CPC, CPMA, CPPM:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram